References
- Burke MJ, Lincoln J. Aripiprazole and haloperidol: a clinically elevant interaction with a dopamine antagonist and partial agonist. Ann Clin Psychiatry. 2006;187:129–130.
- Ahuja N, Lloyd A. Aripiprazole and worsening of psychosis. J Clin Psychiatry. 2007;68:805–806.
- Chouinard G, Jones BD, Annable L. Neuroleptic-induced super-sensitivity psychosis. Am J Psychiatry. 1978;135:1409–1410.
- Inoue A, Mild S, Seto M, Kikuchi T, Morita S, Ueda H, Misu Y, Nakata Y. Aripiprazole, a novel antipsychotic drug, inhibits quin-pirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum. Eur J Pharmacol. 1997;321:105–111.
- Rocha FL, Hara C. Benefits of combining aripiprazole to clozapine: three case reports. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:1167–1169.